Think Tank to States: Use 340B to Reduce Drug Prices
States should do more to help hospitals and other providers enroll in the 340B program as a way to lower drug prices, a liberal think tank with ties to the Obama and Clinton administrations says in a new report.
“The 340B program can result in savings for states both through maximizing participation and ensuring that participating providers are maximizing those savings,” the Center for American Progress (CAP) says in a Feb. 13 paper outlining state policy options to reduce prescription drug spending. Cash-strapped, thinly staffed hospitals, health centers, and clinics might lack resources needed to confirm their eligibility and apply for 340B drug discounts, the center says. States could offer their non-enrolled covered entities help “to ensure that all…are aware of their eligibility under federal law as well as the state regulations on how such hospitals may operate.”
States should do more to help hospitals and other providers enroll in the 340B program as a way to lower drug prices, a liberal think tank with ties to the Obama and Clinton administrations says in a new report.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
